Lineage Cell Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

SEC filing history

Showing 226-250 of 1,000 matching filings.

Per page
25
Current page
10
DEFA14A File 001-12830

DEFA14A filing

Filing date
03 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-12830

DEF 14A filing

Filing date
03 Aug 2021
Reporting date
03 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2021
Reporting date
21 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
01 Jul 2021
Reporting date
21 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Jun 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Jun 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jun 2021
Reporting date
25 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2021
Reporting date
18 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12830

10-Q filing

Filing date
13 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
4

4 filing

Filing date
06 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
06 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .